These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24504395)

  • 1. Big pharma shows signs of renewed interest in RNAi drugs.
    Zeliadt N
    Nat Med; 2014 Feb; 20(2):109. PubMed ID: 24504395
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The industrialization of drug discovery.
    Handen JS
    Drug Discov Today; 2002 Jan; 7(2):83-5. PubMed ID: 11790609
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern methods of drug discovery: an introduction.
    Giersiefen H; Hilgenfeld R; Hillisch A
    EXS; 2003; (93):1-18. PubMed ID: 12613169
    [No Abstract]   [Full Text] [Related]  

  • 6. China spurs pharma innovation.
    Hughes B
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech acquisitions by big pharma: why and what is next.
    Malik NN
    Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Open innovation for Japanese pharmaceutical companies].
    Hoshino T
    Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523
    [No Abstract]   [Full Text] [Related]  

  • 9. European lead factory opens for business.
    Mullard A
    Nat Rev Drug Discov; 2013 Mar; 12(3):173-5. PubMed ID: 23449292
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomedicine. Pharma firms push for sharing of cancer trial data.
    Bhattacharjee Y
    Science; 2012 Oct; 338(6103):29. PubMed ID: 23042862
    [No Abstract]   [Full Text] [Related]  

  • 11. [Open innovation and licensing in the pharmaceutical industry].
    Yamasaki M
    Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225
    [No Abstract]   [Full Text] [Related]  

  • 12. Novelty in the target landscape of the pharmaceutical industry.
    Agarwal P; Sanseau P; Cardon LR
    Nat Rev Drug Discov; 2013 Aug; 12(8):575-6. PubMed ID: 23903214
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoiding premature licensing.
    Kessel M; Hall S
    Nat Rev Drug Discov; 2006 Dec; 5(12):985-6. PubMed ID: 17201025
    [No Abstract]   [Full Text] [Related]  

  • 14. The critical impact of time discounting on economic incentives to overcome the antibiotic market failure.
    Spellberg B; Sharma P; Rex JH
    Nat Rev Drug Discov; 2012 Feb; 11(2):168. PubMed ID: 22293569
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial R&D incentives.
    Laxminarayan R; Powers JH
    Nat Rev Drug Discov; 2011 Sep; 10(10):727-8. PubMed ID: 21959280
    [No Abstract]   [Full Text] [Related]  

  • 16. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes.
    Turner MJ
    Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736
    [No Abstract]   [Full Text] [Related]  

  • 17. Deal watch: Epizyme-Celgene deal signals interest in new class of epigenetic drugs.
    Flemming A
    Nat Rev Drug Discov; 2012 Jun; 11(7):508. PubMed ID: 22743968
    [No Abstract]   [Full Text] [Related]  

  • 18. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michael Rosenblatt.
    Nat Rev Drug Discov; 2016 Sep; 15(10):672. PubMed ID: 27681789
    [No Abstract]   [Full Text] [Related]  

  • 20. Pedro Cuatrecasas.
    Cuatrecasas P
    Nat Rev Drug Discov; 2009 Jun; 8(6):446. PubMed ID: 19483706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.